Speakers and Session Chairs

Slides:



Advertisements
Similar presentations
Postgraduate Course in Pharmaceutical Medicine A warm welcome to all participants.
Advertisements

p53 Revealed character as a tumor suppressor gene in 1989.
Clinical Bioinformatics: the need for CBAS and SCBC in Applied Sciences? Dr James Mah MBBS(Lon), BSc(Hons,Lon). Chair, CBAS 2009 Singapore
Gene regulation in cancer 11/14/07. Overview The hallmark of cancer is uncontrolled cell proliferation. Oncogenes code for proteins that help to regulate.
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
Opener A “Smart Drug”. Figure 17.1 One Gene, One Enzyme (Part 1)
THE GENETIC OF CANCER Increased mitosisTumor formation Tumor suppression gene Hyperactive growth TranslocationPoint mutationAmplification Normal growth.
MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.
Introduction to Virology. Nature of Viruses Viral genome is packaged in protein coat.
“Discovery Of Gene Ripple Effect Which Causes Cervical Cancer to Advance And Spread” May 19 th, 2011
REGULATING the CELL CYCLE
Control of Gene Activity Chapter 17. Controlling gene activity Remember to control the cell one must control protein synthesis. Remember to control the.
Powerpoint Templates Page 1 Powerpoint Templates Gene therapy for melanoma By Mohammed razeeth.S.
GENE REGULATION ch 18 CH18 Bicoid is a protein that is involved in determining the formation of the head and thorax of Drosophila.
RA190 Small Molecule Proteasome Inhibitor for Cancer Therapy.
Regulating the Cell Cycle and Cancer Ms. Cohen. How carefully do cells divide? Quite controlled Some cells divide at different rates –Cells that divide.
Regulation of Gene Expression. You Must Know The functions of the three parts of an operon. The role of repressor genes in operons. The impact of DNA.
Organized by 22 nd March 2012 Time: 9am to 5pm Venue: Centre Point, Faculty of Medicine, UM Co-Joint by  games.,  mysterious gift. Ms Siti Falika Tel:
Chapter 18 Regulation of Gene Expression Dr. Joseph Silver.
OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best.
Decoding the Network Footprint of Diseases With increasing availability of data, there is significant activity directed towards correlating genomic, proteomic,
BIOLOGY CONCEPTS & CONNECTIONS Fourth Edition Copyright © 2003 Pearson Education, Inc. publishing as Benjamin Cummings Neil A. Campbell Jane B. Reece Lawrence.
Eukaryotic Genomes 11 November, 2005 Text Chapter 19.
Host Defense Against Tumors (Tumor Immunity)
Ch 11- Controlling Gene Expression
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
Retroviral oncogenes. Cellular protooncogenes Mutation carrying cells with proliferation advantage Activated protooncogene.
Homework #2 is due 10/17 Bonus #1 is due 10/24 Office hours: M 10/ :30am 2-5pm in Bio 6.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
Regulating Gene Expression To accompany “Regulating Gene Expression” Packet -review packet reading, pictures, and questions.
Gene Expression (Epigenetics) Chapter 19. What you need to know The functions of the three parts of an operon. The role of repressor genes in operons.
Genetics of Cancer. Fig Signaling cell DNA Nucleus Transcription factor (activated) Signaling molecule Plasma membrane Receptor protein Relay proteins.
The Problem of Cancer. What are cancer cells ? Cancerous growth involves unrestrained proliferation (malignancy) and spread (metastasis). Caused by: mutations.
May 18 th, 2007 Biotech Symposium - From Genome to Therapeutics -
Show & Tell Limsoon Wong Kent Ridge Digital Labs Singapore Role of Bioinformatics in the Genomic Era.
THE GENETIC BASIS OF CANCER
Dr. George Geromichalos, Ph.D.
National Conference on
Development, Stem Cells, and Cancer
Cyclins, Mutagens and Oncogenes
Human Immortality.
Targeting p53 for Oncology Drug Discovery
Cancer – a disease of many mutations
Can Drug Discovery Research be Done At An Undergraduate Institution?
Control of Gene Expression
SEMINAR 1. Title : Discovery of Protein-Protein Interaction Modulators Using Affinity-Based High-Throughput Screening 2. Speaker : Hyun-Suk Lim (포항공대 (POSTECH))
AN ATTEMPT TO REVERSE CANCER DRUG RESISTANCE
Gene Expression.
Cancer, reproductive system diseases, lipid metabolism 48 22
p53 function and regulation in normal cells and cancer cells
Controls the Cell Cycle
Regulation of Gene Expression
The Eukaryotic Cell Cycle
Liposome Applications —Creative Biostructure. Creative Biostructure established an advanced and novel Liposomes Platform to faciliate research in membrane.
From Bench to Clinical Applications: Money Talks
Regulation of Gene Expression
Discovering new therapeutic targets in GIST
BIOLOGY 12 Cancer.
Novel nanotechnology approach to target cancer - Switch from Proto-Oncogene to Tumor Suppressor. Alexander Kazansky (Sasha)
Genome Science Theme Seminar
Cancer and the Cell Cycle
Notes: Regulating the Cell Cycle
Bose - Cyclin-dependent Kinase Inhibitor Proteins
Genome Science Theme Seminar
Linkage of ubiquitin system between plant and mammalian
The Stem Cell Niche in Regenerative Medicine
Group 3 Group 3 The “Omes” Precision Cancer Medicine
Compartmentalized cellular functions of KDM4A.
PTEN and p53: Who will get the upper hand?
Introduction to Virology
Presentation transcript:

Speakers and Session Chairs M S Reddy CDFD Javed Iqbal Tamal Das TIFR Hyd Murali Bashyam CDFD Kalyaneswar Mandal TIFR Hyd MUR Naidu Natco Balaji Bhyravbhatla Hylasco Aprotim Mazumder TIFR Hyd Manish Jaiswal TIFR Hyd Ravi Gutti, UoH Mandar Deshmukh CCMB Mahaboobi Jaleel Aurigene Subrahmanyam Vangala ReaGene Prabhat Arya SignMod-Transcell Subhadra Dravida Transcell Oncologics

Lecture Titles Session 2: Aprotim Mazumder, TIFR Hyd Measuring DNA damage responses and associated gene expression changes at a single molecule resolution in cells and tissues Ravi Gutti, UoH MicroRNA therapeutics: Discovering novel targets and developing specific therapy Subrahmanyam Vangala, ReaGene The promise and reality in vitro 3D human models in cancer drug discovery Session 1: MS Reddy, CDFD Dissecting cellular processes using interaction proteomics Tamal Das, TIFR Hyd Mechanobiology of collective cell dynamics: How forces dictate cell migration and competition? Murali Dharan Bashyam, CDFD Studying a novel oncogenic role for a nuclear tumor suppressor when localized to the cytoplasm Session 3: Mahaboobi Jaleel, Aurigene Targeted protein degradation for cancer therapy Kalyaneswar Mandal, TIFR Hyd Mirror-image protein based drug discovery against cancer and other diseases Prabhat Arya, SignMod-Transcell Oncologics Going-in for undruggable targets

Come and join our “Open Door”, Town Hall Session if you are interested and happen to be in the area! Session 4: Town Hall Discussion (Facilitator: Prabhat Arya), 5:00-5:40 pm Will have discussion (5-8 min each) on the following points:   Promoting the team culture / helping each other / respecting each other while reaching-out for our research goals (for ex, setting-up collective objectives). Promoting the entrepreneur culture within our young faculty / researchers. Our role models on the entrepreneurial path. Understanding very early on the hard realties of placing your science onto the entrepreneurial path (in India). Aiming for knowledge-based (with IP portfolio) than service-based biotechs.

Conference Agenda (Snapshot) Location: School of Life Sciences, Ground Floor, Seminar Hall Opening Remarks and Welcome Address 8:50 am – 9:15 am 9:20 am – 11:15 am Session 1: Breaking New Grounds in Signaling   Tea Break: 11:15 am – 11:35 am 11:35 am – 1:35 pm Session 2: Technology-based Applications Lunch Break: 1:25 pm - 2:25 pm 2:30 pm – 3:55 pm Session 3A: Emerging Approaches Leading to Translational Paths Tea Break: 3:50 pm - 4:15 pm 4:15 pm – 5:00 pm Session 3B: Emerging Approaches Leading to Translational Paths 5:00 pm - 5.40 pm Session 4: Town Hall Discussion 5:40 pm - 6:10 pm Closing Remarks and Vote of Thanks

M S Reddy, CDFD: Dissecting cellular processes using interaction proteomics Tamal Das, TIFR Hyd: Mechanobiology of Collective Cell Dynamics: How Forces Dictate Cell Migration and Competition? Murali Bashyam, CDFD: Studying a novel oncogenic role for a nuclear tumor suppressor when localized to the cytoplasm Aprotim Mazumder, TIFR Hyd: Measuring DNA damage responses and associated gene expression changes  Mahaboobi Jaleel, Aurigene: Targeted protein degradation for cancer therapy Ravi Gutti, UoH: MicroRNA  therapeutics: Discovering novel  targets and developing specific therapy Subrahmanyam Vangala, ReaGene: The promise and reality in vitro 3D human models in cancer drug discovery Kalyaneswar Mandal, TIFR Hyd: Mirror-image protein based drug discovery against cancer and other diseases Prabhat Arya, SignMod-Transcell: Going-in for undruggable targets Seminar titles